Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder

ConclusionOur study assessed the impact of EBV status on the presentation and clinical outcome of DLBCL-PTLD in a 148-patient single-institution cohort. 56% of cases were EBV positive. EBV positivity was associated with grafted organ involvement and late PTLD diagnosis. Patients with EBV-negative and EBV-positive disease had similar survival from PTLD diagnosis.DisclosuresMaurer: Celgene: Research Funding; Morphosys: Research Funding; Nanostring: Research Funding. Cerhan: Nanostring: Research Funding; Jannsen: Other: Scientific Advisory Board; Celgene: Research Funding.

Source: Blood - November 21, 2018 Category: Hematology Authors: Fama, A., King, R. L., Maurer, M. J., Ristow, K. M., Macon, W. R., Ansell, S. M., Bennani, N. N., Walker, R. C., Kudva, Y. C., Watt, K. D., Schwab, T. R., Cerhan, J. R., Nowakowski, G. S., Habermann, T. M. Tags: 627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)-Results from Retrospective/Observational Studies: Poster II Source Type: research